The history of Sildenafil presents a complex case for stakeholders in the pharmaceutical sector. While initially a tremendous success, generating huge profits, the exclusivity end and the subsequent arrival of generic versions have considerably impacted revenue. This presents questions about the long-term viability of related therapeutic project… Read More